Archives of physical medicine and rehabilitation
-
Arch Phys Med Rehabil · Jul 2004
Randomized Controlled Trial Multicenter Study Clinical TrialDose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke.
To test the hypothesis that intramuscular (IM) botulinum toxin type A (BTX) reduces excessive muscle tone in a dose-dependent manner in the elbow, wrist, and fingers of patients who experience spasticity after a stroke. ⋯ IM BTX reduced muscle tone in a dose-dependent manner in the elbow, wrist, and fingers of patients who experience spasticity after a stroke but did not appear to affect global quality of life or disability.